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ABSTRACT
TWO REGULATORY ASPECTS OF INO1 TRANSCRIPTION IN YEAST
February, 2015
TSCHEN-WEI CHANG, B.S., CHUNG SHAN MEDICAL UNIVERSITY,
TAICHUNG, TAIWAN
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST
Directed by Professor John M. Lopes

The long term goal of this study is to understand the mechanisms of transcriptional
regulation in the brewer’s yeast - Saccharomyces cerevisiae. This study is focused on
understanding the mechanisms of expression control of a phospholipid biosynthetic gene, INO1.
This study also includes investigation into transcriptional regulation of a gene in tandem
upstream of INO1, called SNA3.
For more than three decades, INO1 expression has been used as a model for
transcription studies. INO1 is repressed under growth conditions with inositol and derepressed
by two transcription activators, Ino2 and Ino4, when the environment lacks inositol. More
recently it was shown that coordination of the centromeric binding factor, Cbf1, with Ino2 and
Ino4 is required for efficient derepression of INO1. Transcription of the INO1 adjacent SNA3
gene is also influenced by inositol. It was shown that INO1 and SNA3 are co-regulated by Cbf1,
Ino2 and Ino4 but the complex mechanism of regulation of these two genes is not yet fully
understood.
A separate aspect of INO1 expression is that it is growth phase regulated. Under inositol
depleted conditions, the expression of INO1 increases during log phase and decreases during
stationary phase. Most genes in yeast are believed to be expressed at a constant level through
all growth phases. It is unclear how INO1 growth phase regulation takes place.
The first part of my work focused on exploring the mechanism through which Cbf1, Ino2
and Ino4 control the inositol-mediated regulation of INO1 and SNA3. This included determining
the necessity of the Cbf1 binding site for Ino2 and Ino4 binding, as well as for the inositol
mediated regulation of INO1 and SNA3. The second part of my work focused on understanding
the growth phase regulation of INO1. This includes examining the expression of INO1 in
individual cells in a growing population.
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CHAPTER 1
INTRODUCTION

1.1 Overview
Transcriptional regulation is fundamental for proper functioning of cells and for life.
Research on the mechanisms that control transcription will help us understand how complex life
is made possible. Several model organisms that share high gene functional similarity with
humans have been applied in transcriptional studies. Among them, the yeast, Saccharomyces
cerevisiae, is the most facile and versatile model system for examining eukaryotic gene function
and regulation. The complete genome sequence of this rapidly replicating eukaryote has been
available to the public since its release in 1996. The ease of culturing and genetic manipulation
made S. cerevisiae an even more valuable model.
One of the target areas for transcriptional research is phospholipid synthesis.
Phospholipids are major components of cellular membranes and are also essential for the
regulation of a diverse set of cellular processes, including signaling, cell division, differentiation
and development(Allen et al., 1988; Block and Pletscher, 1988; Majerus et al., 1988). Altered
regulation of phospholipid biosynthetic genes is often associated with cellular dysfunction
(Greenberg and Lopes, 1996). Considering the importance of phospholipids, it is not surprising
that phospholipid synthesis is highly regulated and strongly conserved in eukaryotes – from
yeast to human. For decades, phospholipid synthesis has been studied in S. cerevisiae and the
information collected has been an invaluable foundation for understanding this process in
higher eukaryotes (Carman and Henry, 1999; Carman and Zeimetz, 1996; Greenberg and Lopes,
1996; Henry and Patton-Vogt, 1998).
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This study is focused on understanding two novel aspects of transcriptional regulation in
S. cerevisiae that involve the phospholipid biosynthetic gene INO1 (Chapter 2 and Chapter 3 in
this thesis). INO1 encodes inositol-3-phosphate synthase (IPS) that is required for the de novo
synthesis of inositol phosphates and inositol-containing phospholipids, like phosphatidylinositol
(PI) and its derivatives(Donahue and Henry, 1981; Klig and Henry, 1984) (Fig. 1.1). Deletion of
INO1 results in auxotrophy for inositol. Inositol auxotrophy is a hallmark of defects in the
transcription machinery because transcription of INO1 is exquisitely sensitive to perturbations in
the transcription machinery.
When exogenous inositol is present (I+), PA is converted into CDP-DAG, and PI synthase
(encoded by PIS1) condenses CDP-DAG and inositol to make PI (Fig. 1.1 A). INO1 is repressed
under this condition. However, when inositol is not supplied exogenously to the cell (I-), it can
be synthesized de novo from G6P via the function of INO1(Culbertson et al., 1976; Lopez et al.,
1999; Murray and Greenberg, 1997) (Fig. 1.1 B).
Not surprisingly, INO1 transcription is regulated by the presence of inositol (Carman and
Han, 2009; Chen et al., 2007; Greenberg and Lopes, 1996; Henry and Patton-Vogt, 1998). Our
current understanding of the mechanism of regulation of INO1 transcription is summarized in
Fig. 1.1 and Fig. 1.2. Under I+ conditions, PA is utilized rapidly to make PI. The drop of PA levels
in the cytoplasm leads to the release of a PA-binding repressor, Opi1p, from the endoplasmic
reticulum (ER). Opi1p immediately translocates into the nucleus and prevents INO1 transcription
by interacting with Ino2, an essential activator for INO1 expression (Greenberg et al., 1982a;
Kaadige and Lopes, 2006; Loewen et al., 2004) (Fig 1.2 A). Under I- conditions, PI synthesis is
limited and PA levels are elevated. The repressor Opi1 binds PA and is retained in the ER, and
INO1 transcription is activated (Fig 1.2 B).
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A.

B.

Figure. 1.1. Yeast PI biosynthetic pathway.
PI can be synthesized (A) directly from exogenously supplied inositol or (B) from glucose-6phosphate. Biosynthetic genes are noted in italics.
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A.

B.

Figure. 1.2. Inositol mediated INO1 regulation.
Transcriptional regulation of INO1 (A) When exogenous inositol is supplied, PA levels drop,
freeing Opi1 from the endoplasmic reticulum (ER). Opi1 enters the nucleus and inhibits INO1
expression by binding to Ino2. (B).When the environment lacks inositol, PA levels accumulate
and the PA-Opi1 complex is bound to the ER, preventing Opi1 from translocating. INO1
transcription is turned on by the activators Ino2 and Ino4.
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Complete derepression of INO1 requires three basic helix loop helix (bHLH) transcription
activators Ino2, Ino4, and Cbf1 (Ambroziak and Henry, 1994; Lopes and Henry, 1991; Nikoloff
and Henry, 1994; Shetty and Lopes, 2010). Ino2 and Ino4 bind as a heterodimer to two
Upstream Activation Sequences (E-boxes 1 and 2) in the INO1 promoter (Koipally et al., 1996),
whereas Cbf1 binds to a region farther upstream of INO1, a region that spans the ORF and the
promoter of a gene in tandem upstream of INO1, called SNA3 (Fig 1.2). The binding of Ino2/Ino4
and Cbf1 are interdependent (Shetty and Lopes, 2010). Interestingly, SNA3 displays the same
inositol-dependent transcriptional regulation as INO1. The transcription factors Cbf1, Ino2, and
Ino4 have also been shown to regulate SNA3 expression, although they function in repression in
the presence of inositol rather than activation in the absence of inositol as is the case with INO1
(Shetty and Lopes, 2010).
INO1 regulation is not only responsive to the availability of environmental inositol, but
also to the growth phases. The transcription of INO1 in a cell culture has been reported to
continuously increase during exponential phase, reach the maximum when the culture hits
stationary phase, and decrease during stationary phase (Lamping et al., 1994; Robinson et al.,
1996). The activity of the INO1 product, IPS, shows a similar pattern (Culbertson et al., 1976).
However, the amount of IPS in the culture does not decrease in stationary phase presumably
because of the stability of IPS (Homann et al., 1987).
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1.2 Organization
The two aspects of transcriptional regulation that this study is focused on are “The
inositol mediated co-regulation of INO1 and SNA3” (Chapter 2) and “The growth phase
regulation of INO1” (Chapter 3). Chapter 4 will summarize the work and provide future
directions.

1.2.1 The inositol mediated co-regulation of INO1 and SNA3
Since SNA3 and INO1 display similar inositol mediated transcriptional regulation and
share the transcription factors Ino2, Ino4, and Cbf1, our lab proposed that SNA3 and INO1
transcription are co-regulated (Shetty and Lopes, 2010). Studies in our lab showed that, while
Cbf1 binding mapped to regions spanning the SNA3 ORF and promoter, Ino2 and Ino4 only bind
to E-boxes 1 and 2 located within the INO1 promoter (Shetty and Lopes, 2010). These studies
also showed that the inositol-mediated regulation of SNA3 is not a function of its upstream
sequences. We suggest a novel transcriptional mechanism in yeast – the first case of
transcriptional regulation of a gene from sequences downstream of that gene. Our goal in
Chapter 2 is to gain understanding of the INO1-SNA3 co-regulation mechanism. We will
approach this goal by answering the following questions. Question 1: Where exactly does Cbf1
bind? Published data from our lab suggested that Cbf1 binds to a region which covers three
Upstream Activation Sequences (UAS): E-boxes 3, 4, and 5 (Shetty and Lopes, 2010). Here we
will determine the Cbf1 binding site(s) and the necessity of the E-boxes 4 and 5 for Ino2 and
Ino4 binding. E-box mutants will be generated in the genome and the binding of the three bHLH
transcription factors will be examined by a ChIP-qPCR method. Question 2: How do E-boxes 4
and 5 affect INO1 and SNA3 expression? No current information informs how these two E-boxes
located within the SNA3 promoter participate in the inositol mediated regulation of INO1 and
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SNA3. The transcription of the two genes will be examined in E-box 4 and E-box 5 mutants using
qRT-PCR. Question 3: Is the inositol mediated regulation of INO1 and SNA3 evolutionary
conserved within the Saccharomyces genus? INO1 and SNA3 expression in I+ and I- media will be
examined in three Saccharomyces species (in addition to S. cerevisiae) by qRT-PCR.

1.2.2 The growth phase regulation of INO1
INO1, as well as many other phospholipid biosynthetic genes, was reported to be
growth phase regulated (Culbertson et al., 1976; Homann et al., 1987; Lamping et al., 1994;
Robinson et al., 1996). In other words, if we record the amount of INO1 transcript normalized
for the transcript level of a housekeeping gene over the course of time, we will observe a curve
instead of a flat line. The expression of INO1 varies with growth phases. Researchers interested
in growth phase regulation have looked into INO1 transcript levels (Lamping et al., 1994;
Robinson et al., 1996), protein levels (Homann et al., 1987), as well as enzymatic activity
(Culbertson et al., 1976). However, the mechanism of the INO1 growth phase regulation remains
obscure and is a subject of our study. In Chapter 3, we will seek answers to the following
question: Is the growth phase regulation of INO1 an effect of equal participation of all cells or is
population dependent? Previous studies examined INO1 growth phase regulation on a
population scale. Our work will investigate the reaction of individual cells in the culture to
growth phase changes. Experiments combine qRT-PCR and fluorescence microscopy.
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CHAPTER 2
THE INOSITOL MEDIATED CO-REGULATION OF INO1 AND SNA3

2.1 Introduction
INO1 (Inositol-3-phosphate synthase) is a structural gene essential for the de novo
synthesis of PI from G6P. In S. cerevisiae, the transcription of INO1 is regulated by inositol
(Ambroziak and Henry, 1994; Hirsch and Henry, 1986; Lopes and Henry, 1991; Nikoloff and
Henry, 1994). The expression of INO1 is repressed in the presence of inositol and derepressed
when inositol becomes limiting. It was previously reported that an upstream tandem transcript
(0.6 Kb) displayed similar regulation (Hirsch and Henry, 1986). The transcript had no known
function but has since been named SNA3.
The inositol mediated regulation of INO1 and SNA3 share at least some of the major
players although these players possess opposite functions in the regulation of the two genes
(Hirsch and Henry, 1986). These main characters include the transcription factors Ino2, Ino4,
Cbf1 and the transcription repressor protein Opi1. The regulation, however, requires not only
the effort of these trans- acting factors, but also cis-acting DNA sequences – two E-boxes in the
intercistronic region. An E-box is a transcription factor binding site where the specific sequence
of DNA, CANNTG, is recognized by bHLH proteins that can bind to it and activate transcription of
the gene.
In an environment where inositol is absent (I-), INO1 transcription is derepressed
(Ambroziak and Henry, 1994; Hirsch and Henry, 1986; Lopes and Henry, 1991; Nikoloff and
Henry, 1994). PA levels increase under I- conditions and PA binds to the repressor protein Opi1.
This results in the binding of Opi1 to an ER integral membrane protein, Scs2, and thus Opi1 is
kept outside of the nucleus (Loewen et al., 2003, 2004). The two bHLH transcription factors
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Ino2p and Ino4p form heterodimers and bind to E-boxes 1 and 2, which are located in the INO1
promoter region (Fig. 2.1) (Ambroziak and Henry, 1994; Koipally et al., 1996). The binding of the
Ino2/Ino4 heterodimers leads to recruitment of the TATA binding protein and the activation of
transcription (Lo et al., 2005). Ino2, Ino4 and their binding sites E-boxes 1 and 2 are essential for
INO1 derepression. More recently, it was shown that complete derepression of INO1 also
requires the Cbf1p bHLH protein that binds to regions upstream of the INO1 promoter,
encompassing the SNA3 gene and its promoter (Shetty and Lopes, 2010). These regions cover
three potential bHLH transcription factor binding sites: the E-boxes 3, 4, and 5. It has not yet
been examined, however, where exactly Cbf1 binds. Ino2, Ino4, and E-boxes 1 and 2 are
essential for INO1 activation, while the absence of Cbf1 causes a dramatic decrease of INO1
expression when compared to WT (Shetty and Lopes, 2010).
When grown in an environment containing inositol (I+), the INO1 gene is repressed
(Brickner and Walter, 2004; Hancock et al., 2006; Kaadige and Lopes, 2003, 2006; Kagiwada and
Hashimoto, 2007; Loewen et al., 2004). Under I+ conditions, the associated decrease in PA levels
results in release of Opi1p from the ER. Opi1 travels into the nucleus where it interacts with Ino2
and prevents INO1 transcription (Gardenour et al., 2004; Heyken et al., 2005; Loewen et al.,
2004; Wagner et al., 2001). In a recent study, it was shown that the binding of Ino2 and Ino4 to
the INO1 promoter region and the binding of Cbf1 to the regions spanning the SNA3 promoter
and the SNA3 ORF are interdependent (Shetty and Lopes, 2010).
It was demonstrated in early S. cerevisiae studies that when regulatory sequences were
inserted downstream of the transcription start site or within the gene, they become inactive and
lose their ability to regulate transcription (Guarente and Hoar, 1984; Struhl, 1984). Thus, it has
long been taken for granted that S. cerevisiae transcriptional regulation can only involve
upstream activation sequences (UAS) that are present within 500bp upstream of the gene but
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not downstream of the gene (Struhl, 1989). However, a computational study published in 2000
suggested that tandem adjacent genes in S. cerevisiae exhibit a high degree of correlation in
gene expression and that only one of the promoters contains the relevant UAS element (Cohen
et al., 2000). The results of this study revealed the possibility of regulation from a downstream
sequence.
A more recent study showed evidence that, while Ino2 and Ino4 regulate SNA3
expression, they do not bind upstream of the SNA3 gene, and that the tandem SNA3-INO1 genes
are subject to regulation from the intergenic region (Shetty and Lopes, 2010). While the
expression pattern of INO1 and SNA3 is identical, it is achieved by opposing mechanisms.
Contrary to INO1, SNA3 transcription is derepressed in the absence of cis- sequences in the
SNA3-INO1 intergenic region or the trans- activators of INO1 acting through this intergenic
region (Shetty and Lopes, 2010). The detailed mechanism of SNA3 regulation is not yet
understood.
In this chapter, we will examine the importance of E-boxes 4 and 5 to Cbf1 (Fig 2.1), Ino2
and Ino4 binding, as well as the importance of these cis- sequences to INO1 and SNA3
regulation. We will also look into the INO1 and SNA3 transcript levels under I+ and I- conditions
in the Saccharomyces species: S. bayanus, S. mikatae, and S. castellii (Fig. 2.2). Homologues of
INO1 and SNA3 can be found in several species of the Saccharomyces genus. It is unclear
whether INO1 and SNA3 expression is also controlled in response to exterior inositol
concentration in these organisms.
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Figure. 2.1. Regulatory sequences of the SNA3 and INO1 loci.
E-boxes are labeled as E.
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Figure. 2.2. Phylogenetic relationships of selected yeast species.
Arrows indicate Saccharomyces species used in this study. Mya stands for million years ago.
This figure is reproduced from
http://www.ucdenver.edu/academics/colleges/medicalschool/programs/Molbio/faculty/Joh
nstonM/Pages/JohnstonM.aspx.
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2.2 Materials and Methods
2.2.1 Strains, media, and growth conditions
The S. cerevisiae strain used in this study was BY4742 (MATα his3-1 leu2-0 lys2-0 ura3-0)
(Brachmann et al., 1998). Strains with genomic TAP-tagged INO2, INO4, and CBF1 were
purchased from Open Biosystems (Huntsville, Alabama, USA) (Ghaemmaghami et al., 2003).
Yeast mutant strains created for this study contain specific point mutations in E-box 4 or
E-box 5 in the SNA3 promoter region. The specific SNA3 promoter element was replaced with
restriction sites to generate mutant alleles in either WT and/or TAP-tagged strains. The mutant
alleles were created using a two-step process (Gray et al., 2004). First, an SNA3 promoter::URA3
strain was generated by replacing 245 base pairs of the SNA3 promoter with the URA3 gene
under the control of its own promoter. The URA3 cassette was flanked by 45 base pairs of DNA
homologous to the SNA3 promoter and was amplified from YEp357R (Myers et al., 1986) using
the SNA3 -200to-245_25bpURA3 F and SNA3 +1to+45_25bpURA3 R primer pair (Table 2.1). The
SNA3 promoter::URA3 strain was then used to generate strains carrying SNA3 promoter mutant
alleles by transforming with PCR products created with the E4 mutation primers, the E5
mutation primers (Table 2.1), and the pGEM-T:SNA3 -310 to +100 plasmid (below) and selecting
on 5’FOA medium.
The Saccharomyces species strains (generously provided by Dr. Mark Johnston,
Washington Univ. School of Medicine, St. Louis, MO) used in this study were: S. bayanus (6236C), S. mikatae (IFO 1815), and S. castellii (NRRL Y-12630) (Cliften et al., 2003). Saccharomyces
genomic sequences were obtained from the Gene/Sequence Resources option and the Fungal
BLAST option of the Saccharomyces Genome Database (SGD) (www.yeastgenome.org; R64-1-1
version).
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Yeast cultures were grown at 30°C in a complete synthetic medium containing 2%
glucose (w/v), but lacking inositol (I-), choline (Kelly and Greenberg, 1990), and uracil (in case of
reporters). Where indicated, 75 µM inositol (I+) and 1 mM choline was added.
Plasmid-containing Escherichia coli DH5α cells (Invitrogen, Carlsbad, CA) were grown at
37°C in Luria–Bertani broth with 50 μg/ml ampicillin. Yeast were transformed using the Lithium
acetate based one-step method (Chen et al., 1992). Genomic DNA was extracted using a Zymo
Yeast DNA extraction kit (Zymo Research, Orange, CA).

2.2.2 Plasmid construction
The TA plasmid pGEM-T was ligated with the PCR product of the SNA3-310to+100
primer pair (Table 2.1), covering the -310 bp to +100 bp region of the SNA3 gene, and was
named pGEM-T:SNA3 -310 to +100.
E-boxes 4 and 5 in the SNA3 promoter (positioned -67 to -72 and -174 to -179,
respectively) were mutagenized using the QuickChange XL Site-Directed Mutagenesis kit
(Stratagene, La Jolla, CA). pGEM-T:SNA3 -310 to +100 was used for this mutagenesis. E4
mutation primers and E5 mutation primers (Table 2.1) were used to create the single E-box
mutants.

2.2.3 RNA Analysis
RNA was isolated from yeast using a glass bead disruption and hot acid phenol method
(Collart and Oliviero, 2001), subjected to DNAse digestion using Promega RQ1 RNase-Free
DNase (Madison, WI), and purified using a ZYMO RNA clean and concentrator kit (Orange, CA).
RNA (1µg) was used to synthesize cDNA using Superscript III reverse transcriptase (Invitrogen,
Carlsbad, CA). For quantification, cDNA was diluted 1:10 and qPCR was performed as previously
described with 500 nM primer concentrations (Jani and Lopes, 2008). INO1, SNA3, and TCM1
14

transcripts from S. cerevisiae were quantified using the INO1+1019to+1226, SNA3+23to+191
and TCM1+794to+945 primer pairs, respectively (Table 2.1). INO1, SNA3, and TCM1 transcripts
from S. bayanus, S. mikatae, and S. castellii were quantified using the INO1 qPCR, SNA3 qPCR,
and TCM1 qPCR primer pairs listed in Table 2.2.

2.2.4 Chromatin Immunoprecipitation (ChIP) assays
ChIP assays were performed as previously described (Aparicio et al., 2004) with some
modifications. Cells were fixed with formaldehyde for 15 minutes. Lysis was performed on a
multivortexer using glass beads. The cell extract was sonicated using a model 100 Sonic
Dismembrator with a Branson 250 Microtip Sonicator (Fisher Scientific, Pittsburgh, PA) at 50%
duty cycle with a power of 6. Sonication was performed 20 x 20 sec with at least 1 min on ice
between pulses to fractionate DNA to ~300 bp. Immunoprecipitations were performed by
incubating 800 μl chromatin with 40 μl IgG sepharose beads for 1 hr on a nutator at room
temperature. Beads were washed twice each with FA lysis buffer, FA lysis buffer containing 500
mM NaCl and ChIP wash buffer followed by a wash with TE buffer. Protein-DNA complexes were
eluted from the beads by incubating the beads in ChIP elution buffer for 10 minutes at 65˚C
followed by TE buffer. The supernatants from the two steps were combined and treated with 25
μg RNAse A (Invitrogen, Carlsbad, CA) and incubated for 15 min at 37˚C. DNA was eluted by
incubating the supernatant at 65˚C O/N with 100 μg Proteinase K (Invitrogen, Carlsbad, CA) and
0.1% SDS. DNA was purified using a Zymo ChIP DNA Clean and Concentrator kit (Orange, CA).
For qPCR analysis, ChIP DNA and Input DNA were diluted 1:10 and 1:100, respectively. qPCR
analysis was performed as previously described (Jani and Lopes, 2008). Primers used for qPCR
analysis are listed in Table 2.1.
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Table 2.1: Oligonucleotides used in this study - A
Oligo

Sequence

SNA3 -200to-245
_25bpURA3
SNA3 +1to+45
_25bpURA3

5’-GTGGGCATATAGTTTTTCGCTATGTATATAGCGGATGAGTGCGTTT
AGCTTTTCAATTCAATTCATCATT-3’
5’-ATAGCTCATTCGATGGTCATGGTCATTAATATGGTCTCTGTCCATTT
AGTTTTGCTGGCCGCATCTTCTC-3’
5’-GGAAAGAGAGTACAGCACGAATGAGCGGCGCCCAGGAAAGGGGC
TAGGTTAAAAAATA-3’
5’-TATTTTTTAACCTAGCCCCTTTCCTGGGCGCCGCTCATTCGTGCTGT
ACTCTCTTTCC-3’
5’-GTATATAGCGGATGAGTGCGTTGGGATTACTATTTCTTTAATGAGG
CCTATGAAGGCTCGTTTTCTTTTTTTTTT-3’
5’-AAAAAAAAAAGAAAACGAGCCTTCATAGGCCTCATTAAAGAAATA
GTAATCCCAACGCACTCATCCGCTATATAC-3’
5’-TTACATTCACCCTACAACAT-3’
5’-CTGGGGGAATGAAAACCGCC-3’
5’-GTATTAAACCGGTCTCCATTGC -3’
5’-CCGACGGGCTTCATATATTTG-3’
5’-ACCATGACCATCGAATGAGC-3’
5’-TGAATGATTGCTGGGAAGAA-3’
5’-CCAGAGCTGGTCAAAGAGGT -3’
5’-ACCGTAGTGGACGAAACCAC-3’
5’-CTTCATCCTTCTTTCCCAGAATATTGAAC-3’
5’-GACGAAAGCTCCAATTTATATACGTCTC-3’
5’-ATTGCCTTTTTCTTCGTTCC-3’
5’-CATTCAACACTTTCGATTCC-3’
5’-CCCTGCAGAGGAATCTCAAG-3’
5’-CACTAAGTACGGCCGGAAGA-3’
5’-TAATTTAGAAATGGACAGAGACCA-3’
5’-GTATCCCTGTTGAACATACCCTTA-3’
5’-ACGTGATGAAGGCTCGTTTT-3’
5’-TGGTTGTTTGCTTTCTGCTG-3’
5’-TCCTCTTTGTGTGGGACGAT-3’
5’-TCAATGCAACGCTTTACTGC-3’

F
R

E4 mutation primer

F

E4 mutation primer

R

E5 mutation primer

F

E5 mutation primer
SNA3-310to+100
SNA3-310to+100
INO1+1019to+1226
INO1+1019to+1226
SNA3 +23to+191
SNA3 +23to+191
TCM1+794to+945
TCM1+794to+945
ChIP fragment A
ChIP fragment A
ChIP fragment B
ChIP fragment B
ChIP fragment C
ChIP fragment C
ChIP fragment D
ChIP fragment D
ChIP fragment E
ChIP fragment E
ChIP fragment F
ChIP fragment F

R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
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Table 2.2: Oligonucleotides used in this study - B
Oligo

S. bayanus INO1 qPCR
S. bayanus INO1 qPCR
S. bayanus SNA3 qPCR
S. bayanus SNA3 qPCR
S. bayanus TCM1 qPCR
S. bayanus TCM1 qPCR
S. mikatae INO1 qPCR
S. mikatae INO1 qPCR
S. mikatae SNA3 qPCR
S. mikatae SNA3 qPCR
S. mikatae TCM1 qPCR
S. mikatae TCM1 qPCR
S. castellii INO1 qPCR
S. castellii INO1 qPCR
S. castellii SNA3 qPCR
S. castellii SNA3 qPCR
S. castellii TCM1 qPCR
S. castellii TCM1 qPCR

Sequence

F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R
F
R

GTATCAAGCCCGTCTCCATTGC
CCCACGGGCTTCATGTATTTG
CGAGCAAGACCGAATGAGATA
TGGATGATAGCTGGGAAGAA
CCAGAGCTGGTCAAAGAGGT
ACCGTAGTGGACGAAACCACC
GTATCAAACCTGTCTCCATCGC
CCAACGGGTTTCATATACTTT
AACACAGAATGAGATACTCC
TGAATAATGGCAGGGAAGAA
CCAGAGCTGGTCAAAGAGGT
ACCGTAGTGAACAAAACCACC
GCATTAGACCAGTATCCATCGC
CCGACGGCGGGCATGTATTTA
ACCATGACCATCGAATA
TGAACGGTTGCTGGGAAGAA
CTAGAGCTGGTCAAAGAGGT
ACCGTAGTGGACGAAACCACC
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2.3 Results
2.3.1 E-box 5 is a Cbf1 binding site, E-box 4 regulates Ino4 binding
The inositol mediated regulation of the tandem gene pair INO1 and SNA3 is regulated by
common transcription regulators (Shetty and Lopes, 2010). These include three bHLH proteins:
Ino2, Ino4, and Cbf1. Ino2 and Ino4 are known to only bind the E boxes 1 and 2 located within
the SNA3-INO1 intergenic region for both INO1 and SNA3 regulation. Previous genome wide
regulator binding studies suggested E-box 5 as a preferred binding site for Cbf1p (Ferreiro et al.,
2004; Harbison et al., 2004). However, this suggestion is based on E-box 5 being a close match to
the consensus Cbf1 binding site because the ChIP study was not designed to distinguish
between E box 4 and E box 5. Furthermore, recent ChIP assays showed that Cbf1p binds
multiple regions across the SNA3 promoter and ORF region (Shetty and Lopes, 2010). It is
unclear at the moment, however, where exactly Cbf1 binds and whether the E-boxes within the
SNA3 promoter and ORF region play a regulatory role for INO1 and SNA3.
To understand the importance of the SNA3 promoter region E-boxes to the binding of
the known regulators, we generated E-box 4 and E-box 5 mutant strains harboring TAP-tagged
Ino2, Ino4 and Cbf1. These mutant strains, along with the cognate wild type strains were grown
under I+ and I- conditions. ChIP-qPCR analysis was performed to quantify the binding of the
transcription factors within fragments A-F spanning the SNA3 promoter-SNA3 ORF-INO1
promoter region (Fig. 2.3 A).
Since the ChIP-qPCR data needs to be normalized for sources of variability, including
amount of chromatin, efficiency of immunoprecipitation, and DNA recovery, we analyzed our
ChIP-qPCR data relative to input as this includes normalization for both background levels and
input chromatin going into the ChIP. The results are plotted in Fig. 2.3, with the fragments A-F
on the X-axis and the ChIP/INPUT ratio on the Y-axis.
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Consistent with published data (Shetty and Lopes, 2010), under both I+ and I- growth
conditions, Cbf1 binding in the wild type based Cbf1 TAP-tagged strain occurs at fragments C-E
with significantly strong binding at fragment E under the I- condition (Fig. 2.3 B). This suggests
that Cbf1 binds to the E-box(es) within this region in response to a decrease in exogenous
inositol.
Cbf1 binding in the E-box 4 mutant Cbf1-TAP tagged strain show characteristics similar
to what was observed in wild type, with binding at fragments C-E under both I+ and I- conditions
and remarkable binding at E under the I- condition (Fig. 2.3 C). From this piece of data, we can
assume that Cbf1 does not bind to the SNA3 promoter region via E-box 4.
When the binding was examined in the E-box 5 mutant Cbf1-TAP tagged strain, there
was again no recognizable Cbf1 binding at fragments A, B, and F, but notably, under the Icondition, the binding at fragments C and D were lowered and the binding at fragment E
showed a 3 fold drop compared with the wild type condition (Fig. 2.3 D). Since the mutation of
E-box 5 results in loss of Cbf1 binding, we identified E-box 5 as the Cbf1 binding site within the
region examined. This conclusion is supported by predictions made in previous studies (Harbison
et al., 2004; Kent et al., 2004).
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Figure. 2.3. Cbf1 binds to E-box 5.
(A) Schematic showing primer positions (A to F) and E-boxes in the SNA3 promoter, SNA3
ORF, and the the INO1SNA3 intergenic region. (B-D) ChIP analysis performed using wild
type or E-box mutant Cbf1 TAP-tagged strains grown under I+ and I- conditions. The data
represent means and standard errors of the means from at least three different
experiments. E-boxes are labeled as E.
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We were next interested to determine if mutating E-boxes 4 and 5 affected Ino2 and
Ino4 binding. The two transcription factors only bind to E-boxes 1 and 2 within our region of
interest. However, it was also shown that the binding of the two proteins is dependent on the
presence of Cbf1 (Shetty and Lopes, 2010). It is possible that the binding site of Cbf1 is also
required for proper Ino2/Ino4 binding. It may also be possible that there are other unknown
transcription factors that bind E-box 4 and somehow interact with the known regulators of INO1
and SNA3.
As expected, Ino2 binding in the wild type based Ino2-TAP tagged strain appeared
within the SNA3-INO1 intergenic region and was elevated in the I- conditions (Fig. 2.4 B), which
is consistent with previously published data (Shetty and Lopes, 2010). Unfortunately, Ino2
binding was also observed further upstream in the SNA3 ORF which is inconsistent with
published results (Fig 2.4B). This may be due to poor sonication in this area. The Ino2 binding
pattern in the E-box 4 and E-box 5 mutant strains do not show recognizable differences (Fig. 2.4
C and D), suggesting that both E-boxes do not have effects on Ino2 binding. However, it is not
possible to draw conclusions because of the lack of consistency with published studies.
In the Ino4-TAP tagged wild type strain, binding was also evident within the SNA3-INO1
intergenic region where Ino4 was reported to bind the E-boxes 1 and 2 and was elevated under
I- conditions (Fig. 2.5 B). When compared with wild type, the binding of Ino4 in the E-box 4
mutant strain showed a generally lower binding at fragments A and B and no obvious effect of
inositol (Fig. 2.5 C). Thus, E-box 4, located within the SNA3 promoter region, is somehow
regulating the binding of Ino4 to its binding sites within the downstream SNA3-INO1 intergenic
region. The mutation at E-box 5 did not appear to have much of an effect on binding of Ino4
although there might have been a slight increase in binding (Fig. 2.5 D).
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Figure. 2.4. E-boxes 4 and 5 do not appear to affect Ino2 binding to the INO1-SNA3 intergenic
region.
(A) Schematic showing primer positions (A to F) and E-boxes in the SNA3 promoter, SNA3
ORF, and the INO1SNA3 intergenic region. (B-D) ChIP analysis performed using wild type or
E-box mutant Ino2 TAP-tagged strains grown under I+ and I- conditions. The data represent
means and standard errors of the means from at least three different experiments. Eboxes are labeled as E.
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Figure. 2.5. E-box 4 regulates binding of Ino4 at the downstream INO1-SNA3 intergenic region.
(A) Schematic showing primer positions (A to F) and E-boxes in the SNA3 promoter, SNA3
ORF, and the INO1SNA3 intergenic region. (B-D) ChIP analysis performed using wild type or
E-box mutant Ino4 TAP-tagged strains grown under I+ and I- conditions. The data represent
means and standard errors of the means from at least three different experiments. Eboxes are labeled as E.
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2.3.2 E-box 4 plays a role in inositol mediated SNA3 regulation
Cis- regulatory elements have been reported to control INO1 and SNA3 expression: Eboxes 1 and 2 are essential for INO1 derepression and an E-box 2 mutation results in SNA3
derepression. Hence, having observed the impact of E-box 4 and E-box 5 mutations on the
binding of the INO1 and SNA3 regulators Cbf1 and Ino4, we were interested in understanding
the effect of these E-boxes on the inositol-mediated regulation of INO1 and SNA3.
To look at the expression of these genes, we generated wild type based E-box 4 and Ebox 5 mutants applying the same method we used for generating the E-box mutants in the TAP
tagged strains and carried out qRT-PCR for wild type, E-box 4 and E-box 5 mutant strains grown
under I+ and I- conditions. The expression values of each of the two genes were normalized to a
constitutively expressed ribosomal protein gene, TCM1.
The data clearly showed that INO1 transcripts were not affected by any of the
mutations, whether looking at the I+ or I- growth condition: INO1 expression is >900 fold up
regulated under derepressing conditions in all three strains (Fig. 2.6 A). We concluded that both
E-boxes 4 and 5 have no significant effect on INO1 regulation.
When compared with the I+ condition, SNA3 expression of the wild type strain showed a
2.5 fold increase when grown in media lacking inositol (Fig. 2.6 B), supporting previous studies
(Hirsch and Henry, 1986; Shetty and Lopes, 2010). The mutation at E-box 5 did not seem to have
altered the regulation of SNA3 (Fig. 2.6 B). It is surprising that E-box 5, a binding site of Cbf1, is
dispensable for SNA3 regulation. Interestingly, however, we observed a 2 fold increase of SNA3
expression in the E-box 4 mutant strain under repressing conditions, whereas the transcript
level under derepressing conditions did not show a big difference compared to wild type (Fig.
2.6 B). This data indicates a repressing role of E-box 4 on SNA3 when inositol is present in the
environment.
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Figure. 2.6. Quantitative analysis of INO1 and SNA3 mRNA in wild type, E-box 4, and E-box 5
mutants.
The bar graphs represent the ratio of INO1 or SNA3 to TCM1. (A) INO1 transcript levels. (B)
SNA3 transcript levels. The data represent means and standard errors of the means from
at least three different experiments. E-boxes are labeled as E.
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2.3.3 The inositol mediated regulation of INO1, but not SNA3, is evolutionary conserved
Several genomes of the Saccharomyces genus have been sequenced and utilized in
comparative studies. Species including S. bayanus, S. mikatae, and S. kudriavzevii are closely
related and physiologically similar to S. cerevisiae. They are capable of forming stable diploids
with each other (Barnett, 1992). The Saccharomyces species including S. castellii and S. kluyveri
are more physiologically different and in most cases do not form stable diploids with S.
cerevisiae (Petersen et al., 1999).
To understand if inositol mediated regulation of INO1 and SNA3 is evolutionary
conserved within the Saccharomyces species, we identified INO1 and SNA3 homologues in S.
bayanus, S. mikatae, and S. castellii using sequences obtained from the Gene/Sequence
Resources option and the Fungal BLAST option of the Saccharomyces Genome Database (SGD).
Primers specific to each species were designed for these genes and a constitutively expressed
ribosomal protein gene, TCM1, and qRT-PCR was carried out. The expression values of INO1 and
SNA3 were normalized to TCM1.
INO1 expression in S. cerevisiae showed a 700 fold increase when cultured without
inositol, compared to cultures grown with inositol (Fig. 2.7 A). A 7 fold up regulation of INO1 was
also triggered by the lack of inositol in S. bayanus (Fig. 2.7 A). In S. mikatae, the level of INO1
expression in I- media was 100 times the expression in I+ media (Fig. 2.7 A). INO1 transcription
in S. castellii was enhanced by 5 fold in response to the lack of inositol (Fig. 2.7 A). The data
clearly showed that the inositol mediated INO1 transcription regulation is evolutionary
conserved within the Saccharomyces genus.
S. cerevisiae SNA3 was 2 fold up regulated under I- conditions as previously reported,
however SNA3 expression in the other three species did not respond to the absence of inositol
(Fig. 2.7 B). SNA3 regulation in the species examined is not controlled by inositol.
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Figure. 2.7. Quantitative analysis of INO1 and SNA3 mRNA in the Saccharomyces genus.
(A) INO1 transcript levels are depicted. (B) SNA3 transcript levels are depicted. The data are
the average of at least three independent experiments. Error bars represent the standard
error of the mean value.
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2.4 Discussion
In this chapter, we have examined the importance of E-boxes 4 and 5 to Cbf1, Ino2 and
Ino4 binding, as well as the importance of these cis- sequences to INO1 and SNA3 regulation. A
summary of previous studies and our new findings is presented in Fig. 2.8.
While Cbf1 preferably binds to fragment E within the SNA3 promoter in wild type and Ebox 4 mutant strains, we observed a dramatic drop of this binding when a mutation was induced
at E-box 5. We identified E-box 5 as a binding site for Cbf1 (A in Fig. 2.8). We found that E-box 4,
located in the SNA3 promoter region, is capable of controlling the binding of Ino4 to its binding
sites within the SNA3-INO1 intergenic region, in response to exterior inositol (B in Fig. 2.8).
When SNA3 expression was examined in the E-box mutant strains, E-box 4 mutation resulted in
an increase of SNA3 expression under repressing conditions (I+), indicating that E-box 4 normally
represses SNA3 when inositol is present (C in Fig. 2.8). SNA3 expression in E-box 5 mutants was
not distinguishable from wild type.
We also looked into regulation of INO1 and SNA3 transcription in the Saccharomyces
species, S. bayanus, S. mikatae, and S. castellii and found that inositol affected expression of
INO1, but not SNA3.
It was previously stated that, while INO1 and SNA3 transcription are both up regulated
under I- conditions and repressed under I+ conditions, the shared transcription factors Ino2,
Ino4, and Cbf1 up regulate INO1 expression (a in Fig. 2.8) but suppress SNA3 expression (b and c
in Fig. 2.8) in response to low inositol concentrations. Ino2, Ino4, and Cbf1 binding have been
reported to be interdependent (d in Fig. 2.8). The E-boxes 1 and 2 are known to be required for
INO1 derepression (e in Fig. 2.8), while E-box 2 represses SNA3 (f in Fig. 2.8).
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Figure. 2.8. Schematic summary of previous studies and our new findings on SNA3 and INO1
co-regulation.
Red capital letters indicate findings of this research. Black lower-case letters indicate findings
from previous. E-boxes are labeled as E.
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Considering additional results from this study, we can conclude that:
1. Although Cbf1 binds to E-box 5 (A in Fig. 2.8), it is functioning through a different
mechanism to promote INO1 expression or to down regulate SNA3 transcription under
I- conditions because a mutation of E-box 5 does not affect the expression of the two
genes.
2. Ino4 binding to the SNA3-INO1 intergenic region is regulated by Cbf1 and E-box4 (d and
B in Fig. 2.8). E-box 4 is responsible for the differential binding of Ino4 under I+ and Iconditions. The presence of the transcription factor Cbf1 enhances Ino4 binding.
3. Since E-box 4 represses SNA3 under I+ conditions (C in Fig. 2.8), it is unlikely that this is
directly done via its regulatory role on Ino4 (B in Fig. 2.8), which was reported to
represses SNA3 only under I- conditions (c in Fig. 2.8). It is possible that other
transcription factors bind E-box 4 and are responsible for the inhibition of SNA3 under
the repressing condition.
4. The reason why E-box 4 controls Ino4 binding but has no significant effect on INO1
regulation may be that the Ino4 binding difference caused by this E-box is not great
enough to trigger a response in INO1 expression.
5. Unpublished data from a previous lab member, Dr. Ameet Shetty, made him conclude
that the SNA3 expression is not an effect of the SNA3 promoter region. In his
experiment, he fused either the 400bp or the 1kb of the upstream region of SNA3
(covering E-boxes 4 and 5) to a lacZ reporter gene on a plasmid and analyzed lacZ
expression by β-gal assays. In our current data, however, we found that E-box 4
represses SNA3 under I+ condition. It is possible that the different results are caused by
the participation of the downstream or the even more upstream regions of SNA3.
6. Inositol mediated INO1 regulation is evolutionarily conserved but SNA3 regulation is
not.
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It would be interesting to know which transcription factors recognize E-box 4 and if and
how significant their effect is on SNA3 and INO1 regulation, as well as the binding of our known
regulators of this system. DNA Pull-down assays using E-box 4 probes and Mass Spectrometry
may give us an insight into the answers of these questions. To date, only inhibitory elements,
either cis- or trans-, were identified for SNA3 regulation. A screen for SNA3 activators would
provide us some missing pieces of information needed to understand the SNA3 regulation as a
whole. It also remains unclear whether the E-box 3, located within the SNA3 ORF, has any
regulatory role on INO1 or SNA3. Mutation studies might shed light on this question.
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CHAPTER 3
THE GROWTH PHASE REGULATION OF INO1

3.1 Introduction
Phospholipids are the major component of biological membranes. A living cell is always
highly engaged in the synthesis of phospholipids and the assembly of phospholipids into
cellular membranes (Homann et al., 1987). There are two highly regulated supply routes of
metabolic phospholipid precursors: direct uptake from the environment and biosynthesis by
the cell itself (Robinson et al., 1996). The presence of soluble precursors in the media plays a
strong regulatory role on the expression of phospholipid biosynthetic enzymes at the level of
transcription (Lamping et al., 1994). Inositol is one of the phospholipid precursors that has a
regulatory effect on the phospholipid biosynthesis and inositol biosynthesis pathways in S.
cerevisiae (Culbertson et al., 1976; Paltauf et al., 1992; Robinson et al., 1996). Inositol is used by
the cell to make Phosphatidylinositol (PI), an essential membrane phospholipid that takes part
in signaling, trafficking, and in many other important cellular processes (Greenberg et al.,
1982b; Bae-Lee and Carman, 1984). For a cell to maintain normal functions and continue
growth, the continuous synthesis of PI is an important task (Homann et al., 1987). Hence, the
pool of inositol has to be sufficient under different growth conditions and in all growth phases.
The gene INO1, encoding inositol-3-phosphate synthase, responds to changes in
environmental inositol concentration. Under conditions where inositol is abundant in the
media (I+), INO1 is repressed. When the inositol provided by the environment is insufficient (I-),
INO1 is derepressed and inositol is synthesized by the cell. In addition to the availability of
environmental inositol, Growth phase also affects inositol biosynthetic activities. The regulation
of many inositol biosynthetic enzymes varies with growth phases. Specifically, when expression
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of these genes or their cognate enzymes is normalized to total protein content or cell number
of the course of a growth cycle, a curve is observed (Fig. 3.1 A) instead of a flat line (Fig. 3.1 B).
Growth phase regulation has also been observed for the inositol-regulated INO1 gene.
Under I- conditions, the amount of INOI mRNA was reported to increase during exponential
growth, reach the maximum as the culture approaches stationary phase, and reduce when the
culture is in the stationary phase (Lamping et al., 1994; Robinson et al., 1996) (Fig. 3.1 A). The
activity of the INO1 product is also increased during exponential growth and reduced in
stationary phase (Culbertson et al., 1976). However, the subunit levels of the INO1 product in
stationary phase did not show corresponding reduction (Homann et al., 1987). It was proposed
that the INO1 product is inactivated in some way during stationary phase (Homann et al.,
1987). The mechanism of the INO growth phase regulation is not well understood and is the
subject of this work.
In this chapter, we will examine how the different growth phases affect INO1
expression. Specifically, does the difference in INO1 expression throughout the growth of a
culture occur as a result cellular or population effects?
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Figure. 3.1. Schematic graphs of gene expression patterns and growth curves.
(A) The expression pattern of a growth phase-regulated gene as a function of the growth curve
of the culture. (B) The expression pattern of gene which is not growth phase-regulated.
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3.2 Materials and Methods
3.2.1 Strains, media, and growth conditions
The S. cerevisiae strains with the GFP-tagged INO1 and TCM1 used in this study were
purchased from Invitrogen (Carlsbad, CA) (Huh et al., 2003). The GFP tag is C-terminally
positioned in the genome and the parent yeast strain was (ATCC 201388: MATa his3D1 leu2D0
met15D0 ura3D0).
Yeast cultures were grown at 30°C in a complete synthetic medium containing 2%
glucose (w/v), 75 µM inositol (I+), and 1 mM choline. Where indicated, 0.7M NaCl was added.
When the culture reached the OD600 of 0.4 (late lag phase), cells were collected, washed with
and transferred into the original volume of complete synthetic medium lacking inositol and
choline (I-). Following the shift in medium, the OD600, INO1 expression, and INO1-GFP
fluorescence was examined (for 300 cells) every hour after the shift until the culture was in
stationary phase (OD600 > 0.9).

3.2.2 RNA Analysis
At each time point, RNA was isolated from yeast using a glass bead disruption and hot
acid phenol method (Collart and Oliviero, 2001), subjected to DNAse digestion using Promega
RQ1 RNase-Free DNase (Madison, WI), and purified using a ZYMO RNA clean and concentrator
kit (Orange, CA). RNA (1µg) was used to synthesize cDNA using Superscript III reverse
transcriptase (Invitrogen, Carlsbad, CA). For quantification, cDNA was diluted 1:10 and qPCR was
performed as previously described with 500 nM primer concentrations (Jani and Lopes, 2008).
INO1 and TCM1 transcripts from S. cerevisiae were quantified using the INO1+1019to+1226 and
TCM1+794to+945 primer pairs, respectively (Table 3.1).
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3.2.3 Microscopy and image analysis
At each time point, 3μl of cells were fixed on a media-based 1% low melting agarose
pad. A coverslip was then applied on top of the agarose pad. Cells were imaged using a Nikon
ECLIPSE E600 microscope, HAMAMATSU ORCA-ER digital camera, and the open lab program

5.5.2 from PerkinElmer (Waltham, Massachusetts) under identical settings: the cells were
imaged using a 28 gain, 150-ms exposure, and a 60× objective under the Phase filter, whereas a
max (255) gain, 750-ms exposure, and a 60× objective was used for imaging the same yeast cells
under the GFP filter. Cells were manually identified and selected, then recorded by a
combination of the MicrobeTracker software (Sliusarenko et al., 2011) and the Matlab R2012a
software from Mathworks (Natick, Massachusetts). Background “fake cells” were generated
using the same method for later subtraction of background fluorescence. A program, Combined
Gui (kindly provided by Dr. Steven Sandler, UMass Amherst Department of Microbiology,
Amherst, MA), was used to analyze the fluorescent images in Matlab R2012a. Information
regarding the fluorescence intensity of each cell, the number of cells selected and the average
fluorescence intensity of the cells selected were acquired. The fluorescence intensity of each cell
was normalized to the average fluorescence intensity of the background. At each of the 10 to 11
time points, 300 cells were selected for analysis for each of the two GFP-tagged strains, growing
in either I+, I+ 0.7M NaCl, I-, or I- 0.7M NaCl media. Any cell having fluorescence greater than
background is considered induced.
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Table 3.1: Oligonucleotides used in this study - C
Oligo

INO1+1019to+1226
INO1+1019to+1226
TCM1+794to+945
TCM1+794to+945

Sequence

F
R
F
R

5’-GTATTAAACCGGTCTCCATTGC -3’
5’-CCGACGGGCTTCATATATTTG-3’
5’-CCAGAGCTGGTCAAAGAGGT -3’
5’-ACCGTAGTGGACGAAACCAC-3’
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3.3 Results
3.3.1 The growth phase regulation of INO1 is cell dependent
3.3.1.1 Growth phase regulation of INO1 in regular media

When we monitored INO1 transcription in the INO1-GFP strain upon transfer into Imedia in the late lag phase and into stationary phase, we found that INO1-GFP expression was
regulated by growth phase, confirming previous results (Fig. 3.2). More specifically, INO1GFP expression levels started out low after the shift into the derepressing medium and
increased throughout the log phase. The expression levels peaked at the beginning of the
stationary phase and continuously decreased after the culture continued into stationary phase.
We sought to answer the question: is the difference in INO1 expression throughout
culture growth cell- or population-dependent? To test this, we recorded the fluorescence
intensity of the INO1-GFP fusion protein in 300 cells each hour after the media shift and until
the culture was in stationary phase. If we plot the percentage of fluorescent cells versus time
and see a vertical line to 100% fluorescent cells, this would tell us that all the cells in the culture
induce INO1-GFP simultaneously (Fig. 3.3 A). If we observed a gradual increasing slope, it would
indicate that there is an increasing number of fluorescent cells (Fig. 3.3 B).
Our results matched the expected results shown in Fig. 3.3 A (Fig. 3.4) with 99% of cells
fluorescing between the 3rd and the 4th hours after the media shift (OD600=0.912). There was no
decrease in fluorescence observed once cells entered the stationary phase, which likely reflects
the stability of the INO1-GFP fusion protein.
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Figure. 3.2. The expression pattern of INO1 mRNA during growth of a culture.
INO1 transcript levels were normalized to TCM1. The binary logarithm of the OD600 readings is
presented.
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Figure. 3.3. Schematic graphs showing the percentage of fluorescent cells in a culture versus
time.
(A) Cell dependent model and (B) population dependent model.
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Figure. 3.4. Percentage of fluorescent INO1GFP cells in the culture versus time.
Cells are considered induced when the fluorescence intensity of the cell is discernable above
the average intensity of the background.
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When we examined the INO1-GFP cells collected from different growth phases, we
were able to quantify the fluorescence intensity in each cell (Fig. 3.5 A). Visual examination
suggested a gradual increase in fluorescence intensity throughout the population of cells. This
was clearly different from the case of the TCM1-GFP control gene where neither the
percentage of fluorescing cells nor the intensity of fluorescence was affected by the growth
phase (Fig. 3.5 B).
To quantify what we observed and confirm that the growth phase regulation of INO1
occurs uniformly throughout the entire population, we binned 300 cells according to their
fluorescence intensity and plotted the results as a function of time after the media shift. We
expected to see one of the two distribution patterns shown in Fig. 3.6. If there is only a small
subset of cells that shifts between the different bins while the rest of the cells stay in the same
bin (Fig. 3.6 A), we can assume that the changes in the amount of the INO1-GFP product in
different growth phases is population dependent. Whereas shifting of the entire population will
support that the model that growth phase regulation of INO1 is cell dependent (Fig. 3.6 B).
In our data, there was no significant fluorescence produced by INO1-GFP when cells
were grown in the repressing media (Fig.3.7 A). Whereas in derepressing media, fluorescence
was first recognizable in 95% of the cells at the 3rd hour (OD600=0.81). In the 4th and the 5th hour
(OD600=0.912 and 0.947, respectively), fluorescence increased reaching a maximum at the 5th
hour (Fig.3.7 B). The TCM1-GFP control strain showed a steady intensity in both I+ and I- media
throughout the different growth phases (Fig. 3.7 C and D).
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A.

B.

Figure. 3.5. Microscope pictures of INO1GFP and TCM1GFP cells at different time points.
(A) Phase contrast and green fluorescen
fluorescence pictures of INO1-GFP cells. (B) Phase contrast and
green fluorescent pictures of TCM1-GFP cells. All pictures are taken under the 60x objective.
Pictures at time 0 were taken directly after the media shift. The O.D.600 levels are shown for
each image.
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A.

B.

Figure. 3.6. Schematic graphs of fluorescence intensity per area over time.
(A) A model for population-dependent regulation. (B) A model for cell-dependent regulation.
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Figure. 3.7. Statistic graphss of fluorescence intensity per area over time.
Statistic graphss of fluorescent in
intensity of INO1GFP cells shifted into I+ media (A) and I- media
(B). Statistic graphss of fluorescent intensity of TCM1GFP cells shifted into I+ media (C) and Imedia (D).. At each time point, 300 cells were examined per strain per media. Data from time 0
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We also examined the average fluorescence intensity of 300 cells at each hour after the
media shift (Fig. 3.8A). The brightness generated by the INO1-GFP product increased throughout
exponential growth (between the 2nd and the 5th hour after the media shift. Again, no decrease
in brightness was observed in the stationary phase, which may be a function of protein stability.
The TCM1-GFP control yielded a constant level of fluorescence (Fig. 3.8B).
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Figure. 3.8. The average fluorescence intensity of the cells examined.
(A) The average fluorescence intensity of INO1GFP cells versus time after the media shift. (B)
The average fluorescence intensity of TCM1GFP cells versus time after the media shift. At
each time point, 300 cells were examined per strain per media. Data from time 0 was
generated by examining cells collected directly after the media shift.

48

3.3.1.2 Growth phase regulation of INO1 under osmotic shock
It has been previously reported that the expression of another growth phase regulated
phospholipid biosynthetic genes, CHO1, was altered in response to osmotic shock. The addition
of 0.7 M NaCl eliminated the effect of the growth phase on the CHO1 expression but did not
affect the inositol response (Robinson et al., 2000). We were curious if and how osmotic shock
affects INO1 growth phase regulation. In contrast to CHO1, we found that the expression of
INO1-GFP was still growth phase regulated (Fig. 3.8). However, the expression levels observed in
the I- osmotic shock media were generally 20 times lower than what we saw in the standard Imedia (compare Fig. 3.8 and Fig. 3.2).
Despite the lower transcript levels of INO1-GFP, the pattern of cells grown under
osmotic shock showing fluorescence was effectively the same as cells grown under normal
conditions (compare Fig. 3.9 and Fig. 3.4).
As we previously observed in the cells grown in I+ media, there was no fluorescence
generated by the INO1-GFP fusion protein in the cells grown under osmotic shock (Fig. 3.6 A and
Fig. 3.10 A, respectively). Under osmotic shock conditions, the induction pattern generally
matched our observations in the standard media (Fig. 3.10 B and Fig. 3.6 B, respectively).
However, the cells in the osmotic shock media generally displayed a broader pattern of
fluorescence intensity than the cells from the standard media (compare Fig. 3.10 B and Fig. 3.6
B). This broader distribution increased in brightness throughout the growth of the culture (Fig.
3.10 B). The control strain with TCM1-GFP was not affected by the osmotic shock (Fig. 3.10 C
and D and Fig. 3.6 C and D).
The average brightness of the cells in osmotic shock I- media followed the same pattern
as in standard I- media. However, starting from the 5th hour after media shift (OD600=0.834),
which was the peak of INO1-GFP mRNA expression was (Fig. 3.8), the intensity of the osmotically
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shocked cells started yielding more intense fluorescence and by the 7th hour, the intensity was
double that of cells in standard I- media (Fig. 3.11 A and Fig. 3.8 A). The variation observed in
Fig. 3.11 A was pronounced because of the wide variety in fluorescence intensity of the cells (Fig
3.10 B).
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Figure. 3.9. The expression pattern of INO1 mRNA in osmotic shock media.
INO1 transcript levels were normalized to TCM1. The binary logarithm of the OD600 readings is
presented.
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Figure. 3.10. Percentage of fluorescent INO1GFP cells in cultures grown in osmotic shock
media versus time.
Cells are considered induced when the fluorescence intensity of the cell is discernable above
the average intensity of the background.
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Figure. 3.12. The average fluorescence intensity of the cells examined.
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osmotic shock media. At each time point, 300 cells were examined per strain per media. Data
from time 0 was generated by examining cells collected directly after the media shift
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3.4 Discussion
In this chapter, we examined how cells respond to growth phases in terms of INO1
regulation. Our data of cells growing in regular I- media agreed with previous reports: the total
INO1 mRNA expression of the culture increased in the exponential phase, reached the maximum
when entering the stationary phase (OD600=0.912) and decreased during stationary phase. Most
individual cells examined in these cultures were involved in contributing to the observed growth
phase regulation. At OD600=0.912, 99% of the cells examined possessed enough fluorescence
from INO1-GFP to be distinguished from the background. Looking at the fluorescence intensity
of each cell, we found that each cell was brighter than as cells progressed through log phase. At
OD600=0.947, which was 1 hour after the peak of INO1 mRNA expression was observed, all cells
showed maximum fluorescence. Surprisingly, the level of fluorescence did not decrease after
entering stationary phase. When examining cells cultured in osmotic shock I- media, the pattern
of all our observations were generally similar to what we have seen in standard media.
However, the INO1 transcription rate was 20 times lower in osmotic shock media than in
standard I- media, with the maximum expression at OD600=0.834. Although the cultures were
started with the same pre-culture and at almost the same concentration (OD600=0.456 and
0.476), in terms of the doubling time and the expression pattern of INO1 transcript, cells in the
osmotic shock environment reached stationary phase at OD600=0.834, which happened 1 hour
later than what we observed in standard media at OD600=0.912. All cells examined in osmotic
shock fluoresced at OD600=0.834 and in general the intensity was greater and more varied than
cells in standard I- media. The average fluorescence intensity of cells grown in osmotic shock Imedia at OD600=0.896 was twice that of standard I- grown cells.
It is possible that there is a mechanism that represses INO1 transcription when the Ino1
protein reaches a certain level in each cell, resulting in the drop of INO1 transcript levels
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observed in the stationary phase. However, we did not observe a decrease in fluorescence as
cells entered stationary. Our microscopy data agreed with previous studies that the amount of
the Ino1 protein activity increases during log phase and stays elevated in stationary phase. The
difference between the patterns of Ino1 protein and the activity of the protein, previously
reported, may be due to post-translational modifications of the protein in the stationary phase
or simply the protein stability. The elevated fluorescence from INO1-GFP in stationary phase
could be due to the stability of the GFP or the fusion proteins.
From our data, we understood that the growth phase regulation of the Ino1 protein is
not a result of change in the amount of INO1 expressed by a certain group, but instead, all
individual cells in the culture are involved. However, we do not know if the cells respond to the
changes in growth phases individually or if there is some communication going on in the culture.
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CHAPTER 4
CONCLUSION

4.1 Summary
This study provides clues for further understanding the mechanism of yeast
transcriptional regulation in response to environmental cues. The two aspects of transcriptional
regulation that were discussed in this study are “The inositol mediated co-regulation of INO1
and SNA3” and “The growth phase regulation of INO1”.
In Chapter 2, we examined the importance of regulatory cis- elements in inositol
mediated transcription control of the phospholipid biosynthetic gene INO1 and the gene
tandemly upstream of INO1, SNA3. We also examined the evolutionary conservation of the
inositol-dependent INO1 and SNA3 regulation in Saccharomyces species. Our major findings
were: 1) the transcription factor Cbf1 binds to E-box 5, located within the SNA3 promoter
region; 2) E-box 5 is not involved in the inositol mediated transcription regulation of INO1 and
SNA3; 3) E-box 4 is involved in the inositol-mediated differential binding of Ino4 to the INO1SNA3 intergenic region; 4) E-boxes 4 and 5 do not affect INO1 expression differently under I+
and I- conditions; 5) E-box 4 represses SNA3 under I+ condition; and 6) inositol-mediated INO1
regulation is evolutionary conserved but SNA3 regulation is not conserved.
In Chapter 3, we examined how individual cells in a culture respond to changes in
growth phase in terms of INO1 regulation. Our data showed that: 1) the growth phase
regulation of INO1 is a result of all individual cells in the culture responding to the growth phase;
and 2) osmotic shock does not eliminate growth phase regulation of INO1 as it does with CHO1.
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4.2 Future work
4.2.1 Inositol-mediated co-regulation of INO1 and SNA3
We observed a role for E-box 4 in inositol-mediated SNA3 regulation: when inositol is
present (I+), E-box 4 represses SNA3 expression. To better understand how E-box 4
accomplishes its regulatory role on SNA3, transcription factors that bind and act through this cisregulatory element need to be identified. The combination of DNA pull-down assays using E-box
4 as probe and Mass Spectrometry may identify trans- acting factors. Mutation studies with the
identified factors, in combination with qRT-PCR and ChIP experiments, can provide clues about
what and how significant their effect is on SNA3 regulation, as well as on the binding of our
known regulators of this system.
The known trans- regulators of SNA3 – Ino2, Ino4, and Cbf1, as well as the cis- acting Eboxes 1, 2, and 4, all play an inhibitory role on SNA3 expression. Since SNA3 must somehow be
up-regulated under inositol lacking conditions (I-), there must also be transcription activators
that are responsible for this response. A possible way of identifying transcription factors that
promote SNA3 expression is to screen through transcription factor mutant strains and search for
mutants that lose the ability to up-regulate SNA3 under I- conditions. Binding sites of putative
transcription factors of interest can be identified via ChIP experiments.
We have examined the effect of E-boxes 4 and 5 on the expression of INO1 and SNA3.
We have also examined the importance of these E-boxes for the binding of the known
regulators of INO1 and SNA3. However, it remains unclear whether E-box 3, located within the
SNA3 ORF, also has a regulatory role on the two genes. To look into this question, the transcript
levels of INO1 and SNA3 in an E-box 3 mutant strain can be examined.
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4.2.2 Growth phase regulation of INO1
The level of INO1 transcription and the level of the INO1 protein activity increase during
exponential phase, reach the maximum at the entry of stationary phase, and decrease during
stationary phase. However, the INO1 protein levels stay high in stationary phase. It is very likely
that the different regulatory patterns of the protein level and the protein activity level are a
result of post-translational modifications of the protein in the stationary phase. To evaluate this
possibility, Mass Spectrometry can be applied to purified exponential phase and stationary
phase INO1 products.
It is clear that every cell in a culture is contributing to the growth phase regulation of
INO1. However, whether the cells respond to the environment individually or via
communication with other cells in the culture remains unknown. Quorum sensing experiments
should be carried out to determine if this is the case.
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